{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:45:43Z","timestamp":1768315543073,"version":"3.49.0"},"reference-count":38,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.3892\/ijo.2015.3294","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T08:26:52Z","timestamp":1450168012000},"page":"734-746","source":"Crossref","is-referenced-by-count":19,"title":["A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells"],"prefix":"10.3892","volume":"48","author":[{"given":"MEIYAN","family":"SHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIA","family":"REN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIDI","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HENGXIAO","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUOQIANG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOFEN","family":"YUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUBO","family":"ZHENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LINCHANG","family":"YU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUFEI","family":"PAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUANHUA","family":"SONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"QIANG","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIANLIAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIAOYU","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZHIYONG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUIFANG","family":"DING","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUOSHENG","family":"JIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,12,15]]},"reference":[{"key":"key20180107185402_b1-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00277-013-1788-z","article-title":"Management of elderly patients with acute promyelocytic leukemia: Progress and problems","volume":"92","author":"Lengfelder","year":"2013","journal-title":"Ann Hematol"},{"key":"key20180107185402_b2-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/shem.2001.20863","article-title":"Treatment of acute promyelocytic leukemia with arsenic compounds: In vitro and in vivo studies","volume":"38","author":"Chen","year":"2001","journal-title":"Semin Hematol"},{"key":"key20180107185402_b3-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"key20180107185402_b4-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"e2012012","DOI":"10.4084\/mjhid.2012.012","article-title":"Epidemiology, diagnosis and treatment of acute promyelocytic leukemia in children: The experience in china","volume":"4","author":"Zhang","year":"2012","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"key20180107185402_b5-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11912-002-0031-1","article-title":"Management of acute promyelocytic leukemia","volume":"4","author":"Tallman","year":"2002","journal-title":"Curr Oncol Rep"},{"key":"key20180107185402_b6-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000046623","article-title":"Advances in the treatment of relapsed acute promyelocytic leukemia","volume":"107","author":"Douer","year":"2002","journal-title":"Acta Haematol"},{"key":"key20180107185402_b7-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood.V99.3.759","article-title":"Acute promyelocytic leukemia: Evolving therapeutic strategies","volume":"99","author":"Tallman","year":"2002","journal-title":"Blood"},{"key":"key20180107185402_b8-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1521-6926(03)00040-9","article-title":"Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia","volume":"16","author":"Sanz","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20180107185402_b9-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1158\/1078-0432.CCR-09-0209","article-title":"Therapy-induced PML\/RARA proteolysis and acute promyelocytic leukemia cure","volume":"15","author":"Nasr","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107185402_b10-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s12185-013-1354-4","article-title":"Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia","volume":"97","author":"Tomita","year":"2013","journal-title":"Int J Hematol"},{"key":"key20180107185402_b11-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.0954-6820.1957.tb00124.x","article-title":"Acute promyelocytic leukemia","volume":"159","author":"Hillestad","year":"1957","journal-title":"Acta Med Scand"},{"key":"key20180107185402_b12-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00277-004-0919-y","article-title":"Antiproliferation effects of oridonin on HL-60 cells","volume":"83","author":"Liu","year":"2004","journal-title":"Ann Hematol"},{"issue":"1p1","key":"key20180107185402_b13-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1111\/j.1751-553X.2009.01147.x","article-title":"Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells","volume":"32","author":"Gao","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"key20180107185402_b14-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1182\/blood-2006-06-032250","article-title":"Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo","volume":"109","author":"Zhou","year":"2007","journal-title":"Blood"},{"key":"key20180107185402_b15-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/1471-2407-10-610","article-title":"Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc","volume":"10","author":"Gao","year":"2010","journal-title":"BMC Cancer"},{"key":"key20180107185402_b16-ijo-48-02-0734","first-page":"139","article-title":"Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells","volume":"40","author":"Chen","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107185402_b17-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells","volume":"92","author":"Marks","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"key20180107185402_b18-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/sj.leu.2403828","article-title":"The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells","volume":"19","author":"Konopleva","year":"2005","journal-title":"Leukemia"},{"key":"key20180107185402_b19-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107185402_b20-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia","volume":"66","author":"Cimino","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107185402_b21-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/sj.leu.2403390","article-title":"Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1","volume":"18","author":"Tang","year":"2004","journal-title":"Leukemia"},{"key":"key20180107185402_b22-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"key20180107185402_b23-ijo-48-02-0734","first-page":"59","article-title":"Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA","volume":"4","author":"Liu","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"key20180107185402_b24-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/20959","article-title":"Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC","volume":"399","author":"Shimizu","year":"1999","journal-title":"Nature"},{"key":"key20180107185402_b25-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2174\/156800909789271512","article-title":"Caspase-independent pathways of programmed cell death: The unraveling of new targets of cancer therapy?","volume":"9","author":"Constantinou","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107185402_b26-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.3748\/wjg.v18.i48.7166","article-title":"Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway","volume":"18","author":"Sun","year":"2012","journal-title":"World J Gastroenterol"},{"key":"key20180107185402_b27-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1471-2407-14-217","article-title":"Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway","volume":"14","author":"Bao","year":"2014","journal-title":"BMC Cancer"},{"key":"key20180107185402_b28-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0145-2126(01)00151-5","article-title":"Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways","volume":"26","author":"Kawagoe","year":"2002","journal-title":"Leuk Res"},{"key":"key20180107185402_b29-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mnfr.200700326","article-title":"Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways","volume":"52","author":"Ramos","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"key20180107185402_b30-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res"},{"key":"key20180107185402_b31-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.leu.2403032","article-title":"Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts","volume":"17","author":"Lunghi","year":"2003","journal-title":"Leukemia"},{"key":"key20180107185402_b32-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1158\/0008-5472.CAN-04-0866","article-title":"Blocking the Raf\/MEK\/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis","volume":"64","author":"Wu","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107185402_b33-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4161\/cbt.6.2.3621","article-title":"Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells","volume":"6","author":"Jin","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"key20180107185402_b34-ijo-48-02-0734","first-page":"647","article-title":"Oridonin induces G2\/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells","volume":"24","author":"Wang","year":"2010","journal-title":"Oncol Rep"},{"key":"key20180107185402_b35-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"key20180107185402_b36-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.cellsig.2006.05.015","article-title":"Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapy","volume":"18","author":"Henson","year":"2006","journal-title":"Cell Signal"},{"key":"key20180107185402_b37-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3892\/or.2013.2888","article-title":"Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK","volume":"31","author":"Bu","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107185402_b38-ijo-48-02-0734","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2010.02.017","article-title":"p38 MAPK and NF-kappaB pathways are involved in naphtho[1,2-b] furan-4,5-dione induced anti-proliferation and apoptosis of human hepatoma cells","volume":"295","author":"Chiu","year":"2010","journal-title":"Cancer Lett"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.3294\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T18:03:37Z","timestamp":1599933817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.3294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,15]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,12,15]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.3892\/ijo.2015.3294"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.3294","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,15]]}}}